Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
GNF 2
Cat No.
CEI-1351
Description
GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl
Product Overview
GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl with an IC50 value of 100 to 300 nM in various cell lines. BCR-ABL gene is fused by the BCR and ABL1 genes. BCR-ABL increased production of tyrosine kinase and played an essential role in the pathogenesis of chronic myelogenous leukemia (CML). Unlike imatinib that competitively inhibited the ATP-binding site of BCR-ABL kinase activity, GNF-2 allosterically inhibited (through binding the myristate-binding site of ABL) the proliferation of BCR-ABL positive cell and induces cell apoptosis. In Ba/F3.p210 Bcr-abl-expressing cells, 48 h treatment of GNF-2 was able to inhibit the proliferation of cells with an IC50 value of 138 nM. In addition, GNF-2 has been found to inhibit E255V and Y253H mutant Ba/F3 cells cell growth, with an IC50 value of 268 and 194 nM, respectively. GNF-2 also caused growth inhibition of K562 and SUP-B15 with an IC50 value of 273 nM and 268 nM, respectively. Injecting with BCR-ABL-expressing Ba/F3-p210 cells, 4 % lymphocytes reduction in eperipheral blood was induced.
CAS No.
778270-11-4
Molecular Weight
374.32
Purity
0.9958
Storage
Store at +4°C
Targets
Bcr-Abl
IC50
268 nM (SUP-B15 cell line) 273 nM (K562 cell line)
Molecular Formula
C18H13F3N4O2
Chemical Name
3-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzamide
Solubility
Soluble in DMSO > 10 mM
Shipping Conditions
Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request
Download
Download Datasheet